The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients

Liu ZiMeng

Status: Unknown

Conditions: Septic Shock; Terlipressin

Treatments: Drug: Terlipressin; Drug: Norepinephrine

Study type: Interventional

Funder types: Other

Identifiers

NCT02306239

2012A080204018

Details and patient eligibility

About

Terlipressin becomes a vasopressin for septic shock. But some studies found it may lead to severe intesitnal complications such as intestinal ischemia. The investigators study was designed to find the effect of terlipressin on intestinal function in septic shock patients.

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• septic shock

Exclusion criteria

• shock due to other reasons
• diagnosited intesitinal ischemia

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

40 participants in 2 patient groups

norepinephrine

Active Comparator group

Description:

patients received norepinephrine

Treatment:

Drug: Norepinephrine

terlipressin

Experimental group

Description:

patients received terlipressin

Treatment:

Drug: Terlipressin